Membrane fluidity modulator
- Incorporation into membrane phospholipids alters bilayer fluidity
- Changes the behavior of embedded receptors and ion channels — an antiarrhythmic rationale
- Incorporation into membrane phospholipids alters bilayer fluidity
- Changes the behavior of embedded receptors and ion channels
Drugs with this mechanism (2)
- Icosapent ethyl — Purified EPA omega-3 that lowers triglycerides and cardiovascular events.
- Omega-3 fatty acids — Mixed EPA/DHA lowers triglycerides but can raise LDL; OTC products are not equivalent.
All mechanisms · Open Membrane fluidity modulator in the interactive console ↗